Gene: FAM107B
Official Full Name: family with sequence similarity 107 member Bprovided by HGNC
Gene Summary: Predicted to act upstream of or within sensory perception of sound. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25424 | FAM107B Knockout cell line (HeLa) | Human | FAM107B | 1:3~1:6 | Negative | Online Inquiry |
KO25425 | FAM107B Knockout cell line (HCT 116) | Human | FAM107B | 1:2~1:4 | Negative | Online Inquiry |
KO25426 | FAM107B Knockout cell line (HEK293) | Human | FAM107B | 1:3~1:6 | Negative | Online Inquiry |
KO25427 | FAM107B Knockout cell line (A549) | Human | FAM107B | 1:3~1:4 | Negative | Online Inquiry |
FAM107B Gene Knockout Cell Lines are specialized cellular models engineered to lack the FAM107B gene, an important player in various biological pathways, particularly those related to cellular proliferation and apoptosis. These knockout cell lines are derived through advanced CRISPR-Cas9 gene-editing technologies, which ensure precise and efficient genetic modification, making them invaluable for researchers seeking to elucidate the specific functions of the FAM107B gene.
The key function of these knockout cell lines lies in their ability to provide insights into the role of FAM107B in different biological processes. By removing the gene, researchers can directly study the downstream effects on cell behavior, signaling pathways, and gene expression profiles. This can lead to a better understanding of FAM107B's involvement in diseases, including cancer and neurodegenerative disorders, ultimately providing a foundation for potential therapeutic targets.
In scientific research and clinical applications, FAM107B Gene Knockout Cell Lines are crucial for elucidating the mechanisms behind gene function and regulation. Their utilization facilitates high-throughput screening, drug response studies, and the investigation of cellular responses in controlled environments. The distinct biological markers they offer can accelerate the discovery of novel treatments, making them a vital resource in both basic research and translational medicine.
One major advantage of our FAM107B Gene Knockout Cell Lines over existing alternatives is their high efficiency and reliability in gene disruption, coupled with comprehensive characterization data that supports reproducibility. Unlike traditional knockdown methods, these knockout cell lines provide a permanent genetic modification, ensuring that experiments yield consistent and meaningful results.
For researchers and clinicians aiming to deepen their understanding of cancer biology or explore therapeutic options, our FAM107B Gene Knockout Cell Lines serve as a critical tool, bridging the gap between experimental research and clinical applicability. With our established reputation for providing high-quality biological products, our team of experts is dedicated to supporting your research endeavors with innovative and reliable solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.